Literature DB >> 9267193

Incidence of fever in the rehabilitation phase following brain injury.

D M Clinchot1, S Otis, S C Colachis.   

Abstract

There appears to be a high incidence of fever after brain injury. The most common cause for fever is infection. The incidence of fever occurring as a result of hypothalamic thermoregulatory dysfunction after brain injury is less clear. This study retrospectively reviewed the charts of 286 subjects with brain injuries. Subject subpopulations were divided into traumatic brain injuries, anoxic brain injuries, and brain injuries resulting from aneurysmal subarachnoid hemorrhage. Fever events were described as any core temperature greater than 99.9 degrees F. Most subjects suffered a severe brain injury and had an average acute hospital length of stay ranging from 35.4 to 60 days. The average rehabilitation length of stay ranged from 38.4 to 45.1 days. Twenty-four percent of subjects experienced fevers, with each of the populations having similar occurrence rates. Unexplained fever events were found in the traumatic brain injury (7%) and aneurysmal subarachnoid hemorrhage (8%) subpopulations only. No unexplained fever event was associated with a temperature greater than 100.8 degrees F.

Entities:  

Mesh:

Year:  1997        PMID: 9267193     DOI: 10.1097/00002060-199707000-00012

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  3 in total

1.  Neurogenic fever after traumatic brain injury: an epidemiological study.

Authors:  H J Thompson; J Pinto-Martin; M R Bullock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

2.  Antipyretic treatment of noninfectious fever in children with severe traumatic brain injury.

Authors:  Jonathon M Brown; Yuthana Udomphorn; Pilar Suz; Monica S Vavilala
Journal:  Childs Nerv Syst       Date:  2007-10-05       Impact factor: 1.475

3.  Paroxysmal autonomic dysregulation with fever that was controlled by propranolol in a brain neoplasm patient.

Authors:  Su Jin Oh; Yun Kyung Hong; Eun-Kee Song
Journal:  Korean J Intern Med       Date:  2007-03       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.